Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Economic evaluation of the Hea...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Economic evaluation of the Heart Protection Study
Bibliographic Details
Main Authors:
Briggs, A
,
Armitage, J
,
Gray, A
,
Mihaylova, B
,
Parish, S
,
Young, A
,
Collins, R
,
Collaborati, H
Format:
Conference item
Published:
2003
Holdings
Description
Similar Items
Staff View
Similar Items
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
by: Mihaylova, B, et al.
Published: (2005)
C-reactive protein in the Heart Protection Study Reply
by: Emberson, J, et al.
Published: (2011)
No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
by: Hopewell, J, et al.
Published: (2009)
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
by: Collins, R, et al.
Published: (2002)
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
by: Mihaylova, B, et al.
Published: (2005)